最后，对我国已上市药品再评价责任主体提出建议。
Finally, to our country already listed drug again evaluation responsibility subjects are proposed.
药品不良反应评价体系是目前上市药品再评价的重要渠道；
The evaluation system of drug adverse reactions is an important channel for re-evaluation of listed drugs.
由于新药上市前临床试验存在许多局限性，故上市后药品再评价非常重要。
The re-evaluation of the effectiveness of new drugs is of great importance when they are in post-market for there exist some limitations in clinical trials before these drugs are put on the market.
应用推荐